Showing results (81-90 of 115) with videos related to
Sort By:
Pageof 12
Cancer Research|June 15, 1989
Circadian rhythm in toxicities and tissue uptake of 1,2-diamminocyclohexane(trans-1)oxalatoplatinum(II) in miceN A Boughattas, F Lévi, C Fournier, et al.The Journal of Pharmacology and Experimental Therapeutics|November 1, 1990
Stable circadian mechanisms of toxicity of two platinum analogs (cisplatin and carboplatin) despite repeated dosages in miceN A Boughattas, F Lévi, C Fournier, et al.International Journal of Cancer|January 10, 2001
Circadian variation in O6-alkylguanine-DNA alkyltransferase activity in circulating blood mononuclear cells of healthy human subjectsC Marchenay, E Cellarier, F Lévi, et al.Hepato-Gastroenterology|May 31, 2001
Chronotherapy of colorectal cancer metastasesF Lévi, S Giacchetti, R Zidani, et al.European Journal of Pharmacology|September 26, 1996
Pharmacokinetically guided melatonin scheduling in rats with circadian system suppressionP Deprés-Brummer, G Metzger, D Morin, et al.Human & Experimental Toxicology|July 1, 1996
Modulation of cisplatin chronotoxicity related to reduced glutathione in miceN A Boughattas, X M Li, J Filipski, et al.Experimental Hematology|January 29, 1999
Chronopharmacologic aspects of continuous AcSDKP infusion in miceX M Li, E Ezan, G Bindoula, et al.European Journal of Cancer (Oxford, England : 1990)|January 1, 1993
Circadian rhythm-modulated chemotherapy with high-dose 5-fluorouracil: a pilot study in patients with pancreatic adenocarcinomaF Bertheault-Cvitkovic, F Lévi, S Soussan, et al.British Journal of Cancer|April 16, 2002
Circadian optimisation of irinotecan and oxaliplatin efficacy in mice with Glasgow osteosarcomaT G Granda, R-M D'Attino, E Filipski, et al.Journal of the National Cancer Institute|June 20, 1990
Phase I trial of 5-day continuous venous infusion of oxaliplatin at circadian rhythm-modulated rate compared with constant rateJ P Caussanel, F Lévi, S Brienza, et al.Pageof 12